Here’s whether Core Scientific, Inc. Common Stock (CORZ) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +201.2%; 3-month momentum positive (+5.1%). Concerns: 50-day MA is falling (-0.13% over 10 days); RSI 83 — overbought, elevated pullback risk. Currently 16.0% off its 52-week high. Score: +3/7.
CORZ is in a confirmed uptrend, trading above both its 50-day ($16.89) and 200-day ($16.46) moving averages. With an RSI of 83.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +201.2% compares to +35.1% for SPY (beat the market by 166.1%).
$10,000 invested 1 year ago→ $30,121 today
vs. S&P 500 (SPY) — same period beat market by 166.1%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($16.46)
✓Above 50-day MA ($16.89)
!RSI(14) neutral zone (30–70) — currently 83.4
✓Positive return (+201.2%)
!Within 10% of period high (−16.0%)
Period Range $19.85
$6.30$23.63
RSI (14) 83.4
0 · OversoldOverbought · 100
Key Metrics
Price$19.85
Period Return+201.2%
Period High$23.63
Period Low$6.30
Drawdown−16.0%
MA-50$16.89
MA-200$16.46
RSI (14)83.4
Avg Volume (30d)11.8M
vs. SPYbeat by 166.1%
Return Rank#101 of 996
Trend Signals
Price is above the 200-day moving average ($16.46)